Namma Metro plans to float tender for 'semi-naming rights' indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Biocon Q4 FY24 profit declines 57% y-o-y to ₹135 cr - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D footprint, eyeing India as a pivotal hub for innovation and clinical trials.
The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference.
Bristol Myers Squibb
aims to expand its research and development presence in
India and expects its newly inaugurated Hyderabad facility to
become its largest unit outside the U.S. by 2025,.